Regeneron Research Facility — Tarrytown, New York

Regeneron Research Facility is a clinical research site located in Tarrytown, New York, United States 10591.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Regeneron Research Facility has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Non-small Cell Lung Cancer, Relapsed and Refractory Multiple Myeloma (RRMM).

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Research Facility?

Regeneron Research Facility has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Research Facility conducted?

Regeneron Research Facility has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Non-small Cell Lung Cancer, Relapsed and Refractory Multiple Myeloma (RRMM).

Is Regeneron Research Facility accredited by Crixeo Health?

Regeneron Research Facility has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regeneron Research Facility?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.